217 related articles for article (PubMed ID: 25205348)
1. Neuroprotective agents target molecular mechanisms of disease in ALS.
Zhu Y; Fotinos A; Mao LL; Atassi N; Zhou EW; Ahmad S; Guan Y; Berry JD; Cudkowicz ME; Wang X
Drug Discov Today; 2015 Jan; 20(1):65-75. PubMed ID: 25205348
[TBL] [Abstract][Full Text] [Related]
2. N-acetyl-l-tryptophan, but not N-acetyl-d-tryptophan, rescues neuronal cell death in models of amyotrophic lateral sclerosis.
Sirianni AC; Jiang J; Zeng J; Mao LL; Zhou S; Sugarbaker P; Zhang X; Li W; Friedlander RM; Wang X
J Neurochem; 2015 Sep; 134(5):956-68. PubMed ID: 26031348
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning.
Kumar V; Islam A; Hassan MI; Ahmad F
Eur J Med Chem; 2016 Oct; 121():903-917. PubMed ID: 27372371
[TBL] [Abstract][Full Text] [Related]
4. Current therapy in amyotrophic lateral sclerosis (ALS): A review on past and future therapeutic strategies.
Wei Y; Zhong S; Yang H; Wang X; Lv B; Bian Y; Pei Y; Xu C; Zhao Q; Wu Y; Luo D; Wang F; Sun H; Chen Y
Eur J Med Chem; 2024 Jun; 272():116496. PubMed ID: 38759454
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic neuroprotective agents for amyotrophic lateral sclerosis.
Pandya RS; Zhu H; Li W; Bowser R; Friedlander RM; Wang X
Cell Mol Life Sci; 2013 Dec; 70(24):4729-45. PubMed ID: 23864030
[TBL] [Abstract][Full Text] [Related]
6. Roots to start research in amyotrophic lateral sclerosis: molecular pathways and novel therapeutics for future.
Harikrishnareddy D; Misra S; Upadhyay S; Modi M; Medhi B
Rev Neurosci; 2015; 26(2):161-81. PubMed ID: 25720096
[TBL] [Abstract][Full Text] [Related]
7. [Neuroprotective therapy for amyotrophic lateral sclerosis (ALS)].
Yanagisawa N; Shindo M
Rinsho Shinkeigaku; 1996 Dec; 36(12):1329-30. PubMed ID: 9128396
[TBL] [Abstract][Full Text] [Related]
8. Therapies in amyotrophic lateral sclerosis-beyond riluzole.
Morrison KE
Curr Opin Pharmacol; 2002 Jun; 2(3):302-9. PubMed ID: 12020475
[TBL] [Abstract][Full Text] [Related]
9. Drug therapy in amyotrophic lateral sclerosis.
Distad BJ; Meekins GD; Liou LL; Weiss MD; Carter GT; Miller RG
Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):633-51, xi-xii. PubMed ID: 18625421
[TBL] [Abstract][Full Text] [Related]
10. DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis.
Feng X; Peng Y; Liu M; Cui L
Neuropharmacology; 2012 Feb; 62(2):1004-10. PubMed ID: 22056419
[TBL] [Abstract][Full Text] [Related]
11. Gemals, a new drug candidate, extends lifespan and improves electromyographic parameters in a rat model of amyotrophic lateral sclerosis.
Nicaise C; Coupier J; Dabadie MP; De Decker R; Mangas A; Bodet D; Poncelet L; Geffard M; Pochet R
Amyotroph Lateral Scler; 2008 Apr; 9(2):85-90. PubMed ID: 18428000
[TBL] [Abstract][Full Text] [Related]
12. Current and prospective disease-modifying therapies for amyotrophic lateral sclerosis.
Morren JA; Galvez-Jimenez N
Expert Opin Investig Drugs; 2012 Mar; 21(3):297-320. PubMed ID: 22303913
[TBL] [Abstract][Full Text] [Related]
13. Nortriptyline delays disease onset in models of chronic neurodegeneration.
Wang H; Guan Y; Wang X; Smith K; Cormier K; Zhu S; Stavrovskaya IG; Huo C; Ferrante RJ; Kristal BS; Friedlander RM
Eur J Neurosci; 2007 Aug; 26(3):633-41. PubMed ID: 17686041
[TBL] [Abstract][Full Text] [Related]
14. The glutamate hypothesis in ALS: pathophysiology and drug development.
Blasco H; Mavel S; Corcia P; Gordon PH
Curr Med Chem; 2014; 21(31):3551-75. PubMed ID: 25245510
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological treatment of ALS.
Münch C; Ludolph AC
Neurol Neurochir Pol; 2001; 35(1 Suppl):41-50. PubMed ID: 11732279
[TBL] [Abstract][Full Text] [Related]
16. [Etiological drug therapy for amyotrophic lateral sclerosis].
Cintas P
Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S220-4S227. PubMed ID: 17128115
[TBL] [Abstract][Full Text] [Related]
17. Amyotrophic lateral sclerosis--a new role for old drugs.
Brown RH
N Engl J Med; 2005 Mar; 352(13):1376-8. PubMed ID: 15800236
[No Abstract] [Full Text] [Related]
18. Experimental trials in amyotrophic lateral sclerosis: a review of recently completed, ongoing and planned trials using existing and novel drugs.
Goyal NA; Mozaffar T
Expert Opin Investig Drugs; 2014 Nov; 23(11):1541-51. PubMed ID: 24965719
[TBL] [Abstract][Full Text] [Related]
19. Strategic approaches to developing drug treatments for ALS.
Vincent AM; Sakowski SA; Schuyler A; Feldman EL
Drug Discov Today; 2008 Jan; 13(1-2):67-72. PubMed ID: 18190866
[TBL] [Abstract][Full Text] [Related]
20. Genistein is neuroprotective in murine models of familial amyotrophic lateral sclerosis and stroke.
Trieu VN; Uckun FM
Biochem Biophys Res Commun; 1999 May; 258(3):685-8. PubMed ID: 10329446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
